Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData’s new report, "Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global cardiac rhythm management devices market. The report provides market landscape, competitive landscape and market trends information the cardiac rhythm management devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Cardiac Resynchronisation Therapy (Cardiac Resynchronisation Therapy – Defibrillators, Cardiac Resynchronisation Therapy – Pacemakers), Implantable Cardioverter Defibrillators (Dual Chamber Implantable Cardioverter Defibrillators, Single Chamber Implantable Cardioverter Defibrillators), and Pacemakers (Dual Chamber Pacemakers, Single Chamber Pacemakers).
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within cardiac rhythm management devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, St. Jude Medical, and Boston Scientific Corporation.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the cardiac rhythm management devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the cardiac rhythm management devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global cardiac rhythm management devices market and the factors shaping it.
1 Table of Contents 3
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 GlobalData Report Guidance 8
3 Disease Overview 9
3.1 Pathophysiology: Cardiac Arrhythmias 9
3.1.1 Tachycardia (Too Fast) 9
3.1.2 Bradycardia (Too Slow) 10
3.1.3 Fibrillation (Quivering) 10
3.1.4 Other Cardiac Disorders 11
3.2 Pathophysiology: Congestive Heart Failure (CHF) 11
3.3 Device Overview 12
3.3.1 Pacemaker 12
3.3.2 Implantable Cardioverter Defibrillator (ICD) 13
3.3.3 Cardiac Resynchronization Therapy (CRT) 13
4 Cardiac Rhythm Management, Global, Market Characterization 15
4.1 Cardiac Rhythm Management Market, Global, Revenue ($m), Historic, 2002–2009 15
4.2 Cardiac Rhythm Management Market, Global, Revenue ($m), Forecast, 2009–2016 16
4.3 Cardiac Rhythm Management Market, Key Technology Trends 17
4.3.1 MRI friendly Pacemakers 17
4.3.2 Wireless Pacemakers 17
4.3.3 Percutaneous Implantable ICDs 17
4.3.4 Automatic Mode Switching by Managed Ventricular Pacing (MVP pacing) 17
4.3.5 Automatic Diagnosis 17
4.3.6 Minute Ventilation Blended Sensor 18
4.3.7 Subcutaneous ICDs 18
4.4 Cardiac Rhythm Management Market, Global, Market Dynamics 18
4.4.1 Market Drivers 19
4.4.2 Market Restraints 23
5 Cardiac Rhythm Management Market, Global, Segment Analysis 26
5.1 Cardiac Resynchronisation Therapy Market, Global, Revenue ($m), Historic, 2002–2009 26
5.2 Cardiac Resynchronisation Therapy Market, Global, Revenue ($m), Forecast, 2009–2016 27
5.3 Cardiac Resynchronisation Therapy, Market Dynamics 28
5.3.1 Market Driver: The Approval of Cardiac Resynchronisation Therapy (CRT) Devices in an Expanded Number of Indications is Driving the Revenue Generation in This Segment. 28
5.3.2 Market Restraint: Effectiveness of Clinical Outcomes through Cardiac Resynchronisation Therapy (CRT) Devices Requires Adequate Skills in Placement of Leads and Continuous Follow up to Avoid Complications 28
5.4 Pacemakers Market, Global, Revenue ($m), Historic, 2002–2009 29
5.5 Pacemakers Market, Global, Revenue ($m), Forecast, 2009–2016 30
5.6 Pacemakers, Market Dynamics 31
5.6.1 Market Drivers 31
5.6.2 Market Restraint: The Demand for Pacemakers Declined Due to Better and More Reliable Technologies 31
5.7 Implantable Cardioverter Defibrillator Market, Global, Revenue ($m), Historic, 2002–2009 32
5.8 Implantable Cardioverter Defibrillator Market, Global, Revenue ($m), Forecast, 2009–2016 33
5.9 Implantable Cardioverter Defibrillator, Market Dynamics 34
5.9.1 Market Driver: Expansion of Implantable Cardioverter Defibrillator (ICD) Use to More Number of Indications ill Increase the Patient Pool 34
5.9.2 Market Restraint: Studies Inferring Complications Associated with the Use of ICDs are a Huge Obstacle for Market Growth 34
6 Cardiac Rhythm Management Market, By Country, 2002–2016 35
6.1 Cardiac Rhythm Management Market, US, Revenue ($m), Historic, 2002–2009 35
6.2 Cardiac Rhythm Management Market, US, Revenue ($m), Forecast, 2009–2016 36
6.3 Cardiac Rhythm Management Market, Canada, Revenue ($m), Historic, 2002–2009 37
6.4 Cardiac Rhythm Management Market, Canada, Revenue ($m), Forecast, 2009–2016 38
6.5 Cardiac Rhythm Management Market, UK, Revenue ($m), Historic, 2002– 2009 39
6.6 Cardiac Rhythm Management Market, UK, Revenue ($m), Forecast, 2009– 2016 40
6.7 Cardiac Rhythm Management Market, Germany, Revenue ($m), Historic, 2002–2009 41
6.8 Cardiac Rhythm Management Market, Germany, Revenue ($m), Forecast, 2009–2016 42
6.9 Cardiac Rhythm Management Market, France, Revenue ($m), Historic, 2002–2009 43
6.10 Cardiac Rhythm Management Market, France, Revenue ($m), Forecast, 2009–2016 44
6.11 Cardiac Rhythm Management Market, Italy, Revenue ($m), Historic, 2002–2009 45
6.12 Cardiac Rhythm Management Market, Italy, Revenue ($m), Forecast, 2009–2016 46
6.13 Cardiac Rhythm Management Market, Spain, Revenue ($m), Historic, 2002–2009 47
6.14 Cardiac Rhythm Management Market, Spain, Revenue ($m), Forecast, 2009–2016 48
6.15 Cardiac Rhythm Management Market, Japan, Revenue ($m), Historic, 2002–2009 49
6.16 Cardiac Rhythm Management Market, Japan, Revenue ($m), Forecast, 2009–2016 50
6.17 Cardiac Rhythm Management Market, China, Revenue ($m), Historic, 2002–2009 51
6.18 Cardiac Rhythm Management Market, China, Revenue ($m), Forecast, 2009–2016 52
6.19 Cardiac Rhythm Management Market, India, Revenues ($m), Historic, 2002–2009 53
6.20 Cardiac Rhythm Management Market, India, Revenue ($m), Forecast, 2009–2016 54
6.21 Cardiac Rhythm Management Market, Australia, Revenue ($m), Historic, 2002–2009 55
6.22 Cardiac Rhythm Management Market, Australia, Revenue ($m), Forecast, 2009–2016 56
6.23 Cardiac Rhythm Management Market, Brazil, Revenue ($m), Historic, 2002–2009 57
6.24 Cardiac Rhythm Management Market, Brazil, Revenue ($m), Forecast, 2009–2016 58
7 Global Cardiac Rhythm Management Market, Strategic Competitive Assessment 59
7.1 Cardiac Rhythm Management Market, Key Participants 60
7.1.1 Medtronic 60
7.1.2 St. Jude Medical, Inc. 61
7.1.3 Boston Scientific Corporation 63
7.1.4 Biotronik SE & Co. KG 63
8 Global Cardiac Rhythm Management Market, Key Marketed Products 65
8.1 Pacemaker – Adapta with MVP Pacing System (Medtronic) 65
8.1.1 Product Description 65
8.1.2 Key Features 65
8.1.3 Clinical Studies and Outcomes 65
8.2 CRT Pacemaker – Anthem RF (St. Jude Medical, Inc.) 66
8.2.1 Product Description 66
8.2.2 Key Features 66
8.3 CRT Defibrillator – Consulta (Medtronic) 67
8.3.1 Product Description 67
8.3.2 Features, Advantages and Benefits 67
8.4 ALTRUA Pacemaker Family (Boston Scientific) 67
8.4.1 Product Description 67
8.4.2 Features, Advantages and Benefits 67
8.5 Subcutaneous Implantable Defibrillator System (Cameron Health, Inc.) 68
8.5.1 Product Description 68
8.5.2 Features, Advantages and Benefits 68
9 Global Cardiac Rhythm Management Market: Strategic Pipeline Assessment 69
9.1 Pipeline Technology Assessment 69
9.2 Cardiac Resynchronisation Therapy, Pipeline Products 71
9.2.1 Protecta XT CRT-D (Medtronic, Inc.) 71
9.2.2 PARADYM 8770 SonR CRT-D (Sorin Group) 72
9.3 Pacemakers, Pipeline Products 72
9.3.1 Revo/EnRhythm MRI Pacemaker System (Medtronic, Inc.) 73
9.3.2 Reply MRI Pacemaker (Sorin Group) 73
9.3.3 External Cardiac Rhythm Normalizer (ECN) Pacemaker (Mathematical Bio-Solutions, Inc.) 74
9.3.4 INGENIO Pacemaker (Boston Scientific Corporation) 74
9.4 Implantable Cardioverter Defibrillators, Pipeline Products 75
9.4.1 PICD-Percutaneous Implantable Cardioverter Defibrillator (InnerPulse, Inc.) 75
9.4.2 Chronicle ICD (Medtronic, Inc.) 76
9.4.3 AnalySt Accel ICD (St. Jude Medical, Inc.) 77
9.5 Other Cardiac Rhythm Management Devices, Pipeline Products 79
9.5.1 Optimizer III System (Impulse Dynamics N.V) 79
10 Global Cardiac Rhythm Management Market, Deals Landscape 80
10.1 Key Deals, 2008–2010 (mid-November) 80
10.1.1 St. Jude Medical Enters into an Agreement with iRhythm Technologies (Partnership) on May 13, 2010 80
10.1.2 Proteus Biomedical Secures $25m in Series E Financing Round (Venture Financing) on April 21, 2010 80
10.1.3 Trivitron Signs an Agreement with Boston Scientific (Partnership) on November 4, 2008 80
11 Appendix 81
11.1 Definitions 82
11.1.1 Cardiac Rhythm Management 82
11.2 Acronyms 83
11.3 Sources 84
11.4 Research Methodology 84
11.5 Secondary Research 85
11.6 Primary Research 85
11.7 Models 85
11.8 Forecasts 86
11.9 Expert Panels 86
11.10 GlobalData Consulting 86
11.11 Contact Us 86
11.12 Disclaimer 86
St. Jude Medical, Inc.
Boston Scientific Corporation
Biotronik SE & Co. KG
Other selected research from the 'Medical Devices' category:
Cardiac Rhythm Management (CRM) Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Stakeholder Opinions: Diabetic Renal Disease
Other selected research from the 'Cardiovascular' category:
Antithrombotics Market Forecast 2009
The Top 10 Cardiovascular Device Companies: Market trends, growth strategies, and SWOT analyses